propanolamines

Preferred Label : propanolamines;

MeSH definition : AMINO ALCOHOLS containing the propanolamine (NH2CH2CHOHCH2) group and its derivatives.;

MeSH synonym : aminopropanols;

Is substance : O;

Details

Origin ID

D011412;

UMLS CUI

C0033442;

Allowable qualifiers
- administration and dosage [MeSH Qualifier]
- adverse effects [MeSH Qualifier]
- agonists [MeSH Qualifier]
- analysis [MeSH Qualifier]
- antagonists and inhibitors [MeSH Qualifier]
- blood [MeSH Qualifier]
- cerebrospinal fluid [MeSH Qualifier]
- chemical synthesis [MeSH Qualifier]
- chemistry [MeSH Qualifier]
- classification [MeSH Qualifier]
- contraindications [MeSH Qualifier]
- economics [MeSH Qualifier]
- history [MeSH Qualifier]
- immunology [MeSH Qualifier]
- isolation and purification [MeSH Qualifier]
- metabolism [MeSH Qualifier]
- pharmacokinetics [MeSH Qualifier]
- pharmacology [MeSH Qualifier]
- poisoning [MeSH Qualifier]
- radiation effects [MeSH Qualifier]
- standards [MeSH Qualifier]
- supply and distribution [MeSH Qualifier]
- therapeutic use [MeSH Qualifier]
- toxicity [MeSH Qualifier]
- urine [MeSH Qualifier]
Currated CISMeF NLP mapping
- 3-aminopropan-1-ol [Substance BNPC]
- Propanolamine (substance) [SNOMED CT concept]
Record concept(s)
- propanolamines [MeSH concept]
Related MeSH Supplementary Concept(s)
- ((1,1-dimethylethyl)amino)-3-(2-(2-(3-methyl-5-isoxazolyl)ethenyl)phenoxy)-2-propanol [MeSH Supplementary Concept]
- (2RS)-1-(1H-indol-4-yloxy)-3-((2-(2-methoxyphenoxy)ethyl)amino)propan-2-ol [MeSH Supplementary Concept]
- (4-azido-3-iodobenzyl)carazolol [MeSH Supplementary Concept]
- (S)-2-amino-1-propanol [MeSH Supplementary Concept]
- 1,1'-(2-phenylenedioxy)bis(3-isopropylamino)-2-propanol [MeSH Supplementary Concept]
- 1,2-dilinoleyloxy-3-dimethylaminopropane [MeSH Supplementary Concept]
- 1,3-bis(N-2-(hydroxyethyl)lauroylamino)-2-hydroxypropane [MeSH Supplementary Concept]
- 1,3-diamino-2-propanol [MeSH Supplementary Concept]
- 1-(((3,4-dimethoxyphenyl)ethyl)amino)-3-(4-hydroxyphenoxy)-2-propanol [MeSH Supplementary Concept]
- 1-(1-fluoropropan-2-ylamino)-3-(2-cyclohexylphenoxy)propan-2-ol [MeSH Supplementary Concept]
- 1-(1-fluoropropan-2-ylamino)-3-(3-tolyloxy)propan-2-ol [MeSH Supplementary Concept]
- 1-(1H-indol-4-yloxy)-3-((2-(2-methoxyphenoxy)ethyl)amino)propan-2-ol [MeSH Supplementary Concept]
- 1-(2-(2-methoxyphenylamino)ethylamino)-3-(naphthalene-1-yloxy)propan-2-ol [MeSH Supplementary Concept]
- 1-(2-(3-methoxyphenyl)ethyl)phenoxy-3-(dimethylamino)-2-propanol [MeSH Supplementary Concept]
- 1-(2-dimethylaminoethyl)-3-(2,3-di(tetradecoxy)propyl)urea [MeSH Supplementary Concept]
- 1-(4-nitrophenyl)-2-(methionylsulfonamido)-1,3-propadiol [MeSH Supplementary Concept]
- 1-(7-methoxy-1H-indol-4-yloxy)-3-(2-(2-methoxyphenoxy)ethylamino)propan-2-ol [MeSH Supplementary Concept]
- 1-(benzylmethylamino)-3-(alpha,alpha,alpha-trifluoro-3-tolyl)oxy-2-propanol [MeSH Supplementary Concept]
- 1-(isopropylamino)-3-(5-((isopropylamino)methyl)-2-methoxyphenoxy)propan-2-ol [MeSH Supplementary Concept]
- 1-(tert-butylamino)-3-(5-tert-butylaminomethyl-2-methoxyphenoxy)propan-2-ol [MeSH Supplementary Concept]
- 1-acetamino-3-(1-naphthyloxy)-2-propanol [MeSH Supplementary Concept]
- 1-amino-3-methoxypropan-2-ol [MeSH Supplementary Concept]
- 1-aminopropanediol [MeSH Supplementary Concept]
- 1-hydroxycarvedilol O-glucuronide [MeSH Supplementary Concept]
- 1-phenyl-2-hexadecanoylamino-3-pyrrolidino-1-propanol [MeSH Supplementary Concept]
- 1-phenyl-2-palmitoylamino-3-pyrrolidino-1-propanol [MeSH Supplementary Concept]
- 2-(1-hydroxyethyl)-7-(2-hydroxy-3-isopropylaminopropoxy)benzofuran glucuronide [MeSH Supplementary Concept]
- 2-(2-hydroxy-3-isopropylaminopropoxy)iodobenzene [MeSH Supplementary Concept]
- 2-(2-hydroxy-3-isoprpylaminopropoxy)-5-(propoxymethy)acetophenone [MeSH Supplementary Concept]
- 2-(3-azido-4-octylphenethyl)-2-aminopropane-1,3-diol [MeSH Supplementary Concept]
- 2-(5-methoxy-3-indolyl)-3-aminopropanol [MeSH Supplementary Concept]
- 2-(N,N-dimethylamino)-2-methyl-1-propanol [MeSH Supplementary Concept]
- 2-(N-myristoylamino)-1-phenyl-1-propanol [MeSH Supplementary Concept]
- 2-(hydroxyethyl)-7-(2-hydroxy-3-isopropylaminopropoxy)benzofuran [MeSH Supplementary Concept]
- 2-I-ICI-H [MeSH Supplementary Concept]
- 2-N-(16-(1'-pyridinium)hexadecanoylamino)-1-(4'-nitrophenyl)-1,3-propandiol [MeSH Supplementary Concept]
- 2-N-(tetradecylamino)-1-phenyl-1,3-propanediol [MeSH Supplementary Concept]
- 2-N-myristoylamino-1-(4-nitrophenyl)-1,3-propandiol [MeSH Supplementary Concept]
- 2-amino-2-(2-(2'-fluoro-4'-(4-methylphenylthio)biphenyl-4-yl)ethyl)propane-1,3-diol [MeSH Supplementary Concept]
- 2-amino-2-methyl-1-propanol [MeSH Supplementary Concept]
- 2-amino-3-hydroxy-2-hydroxymethylpropyl 3-acetylbetulinoate [MeSH Supplementary Concept]
- 2-amino-N-(1-(2-amino-3-(4-aminophenyl)-3-hydroxypropylamino)-1-oxo-3-phenylpropan-2-yl)-4-methylpentanamide [MeSH Supplementary Concept]
- 2-aminopropanol [MeSH Supplementary Concept]
- 2-fluoro-3-(tert-butylamino)-1-(3,4-dihydroxyphenoxy)-2-propanol [MeSH Supplementary Concept]
- 2-nitrilophenoxypropanolamine [MeSH Supplementary Concept]
- 3',4'-ethylenedioxyphenyl-2-palmitoylamino-3-pyrrolidino-1-propanol [MeSH Supplementary Concept]
- 3,4-dihydro-8-(2-hydroxy-3-isopropylaminopropoxy)-2H-1-benzopyran-3-ol [MeSH Supplementary Concept]
- 3-((2-(dipropylamino)-1,2-dipyridin-2-ylethyl)(propyl)amino)propane-1,2-diol [MeSH Supplementary Concept]
- 3-((3-(4-chloro-3-ethylphenoxy)phenyl)(3-(1,1,2,2-tetrafluoroethoxy)benzyl)amino)-1,1,1-trifluoropropan-2-ol [MeSH Supplementary Concept]
- 3-(2-ethylphenoxy)-1-(1,2,3,4-tetrahydronaphth-1-ylamino)-2-propanol oxalate [MeSH Supplementary Concept]
- 3-(3-cyano-4-((3-((1,1-dimethyl-2-(2-naphthalenyl)ethyl)amino)-2-hydroxypropyl)oxy)phenyl)propanoic acid [MeSH Supplementary Concept]
- 3-(3-isopropylamino-2-hydroxypropoxy)estra- 1,3,5(10)-trien-17-one [MeSH Supplementary Concept]
- 3-(4-iodophenoxy)-1-isopropylaminopropan-2-ol [MeSH Supplementary Concept]
- 3-(methylamino)-2-(naphthalen-2-yl)-1-phenylpropan-1-ol [MeSH Supplementary Concept]
- 3-(tert-butylamino)-1-(3,4-dihydroxy-6-fluorophenoxy)-2-propanol [MeSH Supplementary Concept]
- 3-amino-1-propanol [MeSH Supplementary Concept]
- 3-diethylamino-1-propanol 2-phenylbenzoate [MeSH Supplementary Concept]
- 3-methoxyphenylaminopropan-1-ol [MeSH Supplementary Concept]
- 4'-hydroxy-1-phenyl-2-palmitoylaminio-3-pyrrolidino-1-propanol [MeSH Supplementary Concept]
- 4-(3-isopropylamino-2-hydroxypropoxy)-3-(propoxymethyl)acetophenone [MeSH Supplementary Concept]
- 4-(3-isopropylaminohydroxypropoxy)-3-(pentyloxymethyl)acetophenone [MeSH Supplementary Concept]
- 4-(acetylamino)benzoic acid-1-(dimethylamino)-2-propanol [MeSH Supplementary Concept]
- 4-(bromoacetamido)benzyl-1-iodocarazolol [MeSH Supplementary Concept]
- 4-(bromoacetamido)benzylcarazolol [MeSH Supplementary Concept]
- 4-aminobenzylcarazolol [MeSH Supplementary Concept]
- 4-azido-3-iodobenzylcarazolol [MeSH Supplementary Concept]
- 4-azidobenzylcarazolol [MeSH Supplementary Concept]
- 4-hydroxybevantolol [MeSH Supplementary Concept]
- 4-hydroxybunitrolol [MeSH Supplementary Concept]
- 4-hydroxyphenyl carvedilol [MeSH Supplementary Concept]
- 4-hydroxytertatolol [MeSH Supplementary Concept]
- 5'-((N-(2-decanoylamino-3-hydroxy-3-phenylpropyloxycarbonyl)glycyl)amino)-5'-deoxyuridine [MeSH Supplementary Concept]
- 5'-O-(((2-decanoyl-amino-3-hydroxy-3-phenylpropyloxycarbonyl)amino)sulfonyl)-2',3'-O-isopropylideneuridine [MeSH Supplementary Concept]
- 5'-O-(((2-decanoylamino-3-hydroxy-3-phenylpropyloxycarbonyl)amino)sulfonyl)uridine [MeSH Supplementary Concept]
- 5-(3-tert-butylamino-2-hydroxypropyl)-8-hydroxy-3,4-dihydrocarbostyril [MeSH Supplementary Concept]
- 5-hydroxybucindolol [MeSH Supplementary Concept]
- 7-(2-hydroxy-3-tert-butylaminopropoxy)phthalide [MeSH Supplementary Concept]
- 711389-S [MeSH Supplementary Concept]
- 8-hydroxycarvedilol O-glucuronide [MeSH Supplementary Concept]
- ALS 8123 [MeSH Supplementary Concept]
- AMPD 4 [MeSH Supplementary Concept]
- AZD9343 [MeSH Supplementary Concept]
- An-2 compound [MeSH Supplementary Concept]
- B 24-76 [MeSH Supplementary Concept]
- BFE 37 [MeSH Supplementary Concept]
- BFE 55 [MeSH Supplementary Concept]
- BFE 61 [MeSH Supplementary Concept]
- BM 910228 [MeSH Supplementary Concept]
- BRL 14342 [MeSH Supplementary Concept]
- BW 65-54 [MeSH Supplementary Concept]
- BW-A 575C [MeSH Supplementary Concept]
- CBP-93872 [MeSH Supplementary Concept]
- CGP 12177 [MeSH Supplementary Concept]
- CGP 12177-NBD [MeSH Supplementary Concept]
- CGP 55845A [MeSH Supplementary Concept]
- DMG-B13 [MeSH Supplementary Concept]
- E 3753 [MeSH Supplementary Concept]
- FP 33 [MeSH Supplementary Concept]
- GR 81706 [MeSH Supplementary Concept]
- H 142-08 [MeSH Supplementary Concept]
- H 201-70 [MeSH Supplementary Concept]
- H 216-44 [MeSH Supplementary Concept]
- H 224-45 [MeSH Supplementary Concept]
- H 64-52 [MeSH Supplementary Concept]
- H 95-71 [MeSH Supplementary Concept]
- HCL 31D [MeSH Supplementary Concept]
- HI 42 [MeSH Supplementary Concept]
- HX-CH 44BS [MeSH Supplementary Concept]
- ICI 118551 [MeSH Supplementary Concept]
- ICI 119033 [MeSH Supplementary Concept]
- ICI 89406 [MeSH Supplementary Concept]
- ICI 89963 [MeSH Supplementary Concept]
- IPS 339 [MeSH Supplementary Concept]
- JTT 305 [MeSH Supplementary Concept]
- K 4540 [MeSH Supplementary Concept]
- KC 3791 [MeSH Supplementary Concept]
- KF 4317 [MeSH Supplementary Concept]
- KF 577 [MeSH Supplementary Concept]
- KMUP 880602 [MeSH Supplementary Concept]
- L 643717-01J10 [MeSH Supplementary Concept]
- L 653328 [MeSH Supplementary Concept]
- L 8429 [MeSH Supplementary Concept]
- LCL-464 [MeSH Supplementary Concept]
- LI 32-468 [MeSH Supplementary Concept]
- LL 21-945 [MeSH Supplementary Concept]
- M 66,368 [MeSH Supplementary Concept]
- M 66,527 [MeSH Supplementary Concept]
- MK 142 [MeSH Supplementary Concept]
- MNIP [MeSH Supplementary Concept]
- N,N'-(2-hydroxy-1,3-propanediyl)-bis(2-iodoacetamide) [MeSH Supplementary Concept]
- N,N-dimethylaminoisopropanol [MeSH Supplementary Concept]
- N-(1-(4-nitrophenyl)-1,3-dihydroxyprop-2-yl)tetradecanamide [MeSH Supplementary Concept]
- N-decanoyl-2-amino-2-methylpropanol [MeSH Supplementary Concept]
- N-palmitoylserinol [MeSH Supplementary Concept]
- N-stearylserinol [MeSH Supplementary Concept]
- O-(2-hydroxy-3-(tert-butylamino)propyl)-3,3,5-trimethylcyclohexanone oxime [MeSH Supplementary Concept]
- P 0160 [MeSH Supplementary Concept]
- PF-244 [MeSH Supplementary Concept]
- PG394 compound [MeSH Supplementary Concept]
- PG418 compound [MeSH Supplementary Concept]
- PS-6 [MeSH Supplementary Concept]
- REN-293 [MeSH Supplementary Concept]
- ROM 195 [MeSH Supplementary Concept]
- ROM 196 [MeSH Supplementary Concept]
- ROM 203 [MeSH Supplementary Concept]
- ROM 205 [MeSH Supplementary Concept]
- RS 52367 [MeSH Supplementary Concept]
- S 5984 [MeSH Supplementary Concept]
- SB 209995 [MeSH Supplementary Concept]
- SB 211475 [MeSH Supplementary Concept]
- SC 795 [MeSH Supplementary Concept]
- SK&F 16805-A [MeSH Supplementary Concept]
- SMY-540 [MeSH Supplementary Concept]
- STD-101-D1 [MeSH Supplementary Concept]
- Syl930 [MeSH Supplementary Concept]
- T5342126 [MeSH Supplementary Concept]
- TR 2732 [MeSH Supplementary Concept]
- U 10029A [MeSH Supplementary Concept]
- UM 301 [MeSH Supplementary Concept]
- UM-424 [MeSH Supplementary Concept]
- VULM 411 [MeSH Supplementary Concept]
- WAY 123223 [MeSH Supplementary Concept]
- YB-11 [MeSH Supplementary Concept]
- ZAMI 1305 [MeSH Supplementary Concept]
- adimolol [MeSH Supplementary Concept]
- almokalant [MeSH Supplementary Concept]
- alpha-oleoyl oleylamine serinol [MeSH Supplementary Concept]
- amiselimod [MeSH Supplementary Concept]
- amiselimod phosphate [MeSH Supplementary Concept]
- arotinolol [MeSH Supplementary Concept]
- befunolol [MeSH Supplementary Concept]
- benzoral [MeSH Supplementary Concept]
- beta-cyclodextrin-2-hydroxy-3-trimethylammoniumpropyl ether chloride [MeSH Supplementary Concept]
- bevantolol [MeSH Supplementary Concept]
- bometolol [MeSH Supplementary Concept]
- bornaprolol [MeSH Supplementary Concept]
- bucindolol [MeSH Supplementary Concept]
- bucumolol [MeSH Supplementary Concept]
- bufeniode [MeSH Supplementary Concept]
- bufetolol [MeSH Supplementary Concept]
- bunitrolol [MeSH Supplementary Concept]
- butofilolol [MeSH Supplementary Concept]
- carazolol [MeSH Supplementary Concept]
- carazolol glucuronide [MeSH Supplementary Concept]
- cephedrine [MeSH Supplementary Concept]
- cericlamine [MeSH Supplementary Concept]
- cicloprolol [MeSH Supplementary Concept]
- clofedanol [MeSH Supplementary Concept]
- codeine, dioxethedrin, promethazine drug combination [MeSH Supplementary Concept]
- decominol [MeSH Supplementary Concept]
- dehydrozingeronolol [MeSH Supplementary Concept]
- desmethylcarvedilol [MeSH Supplementary Concept]
- dextran-(1,6-bis(2-hydroxypropyl-1-amino)hexane)-dextran [MeSH Supplementary Concept]
- diisopropanolamine [MeSH Supplementary Concept]
- dimethocaine [MeSH Supplementary Concept]
- dioxethedrin [MeSH Supplementary Concept]
- dridocainide [MeSH Supplementary Concept]
- emixustat [MeSH Supplementary Concept]
- epanolol [MeSH Supplementary Concept]
- ersentilide [MeSH Supplementary Concept]
- esmolol [MeSH Supplementary Concept]
- esprolol [MeSH Supplementary Concept]
- exaprolol [MeSH Supplementary Concept]
- falintolol [MeSH Supplementary Concept]
- flestolol [MeSH Supplementary Concept]
- flumolol [MeSH Supplementary Concept]
- fluorocarazolol [MeSH Supplementary Concept]
- fluoroethylcarazolol [MeSH Supplementary Concept]
- girodazole [MeSH Supplementary Concept]
- hydroxypropyl bis(N-hydroxyethyl-p-phenylenediamine) [MeSH Supplementary Concept]
- indenolol [MeSH Supplementary Concept]
- iosmin [MeSH Supplementary Concept]
- isamoltane [MeSH Supplementary Concept]
- isotiod [MeSH Supplementary Concept]
- ko 1124 [MeSH Supplementary Concept]
- ko 1313 [MeSH Supplementary Concept]
- koe 3290 [MeSH Supplementary Concept]
- monoisopropanolamine [MeSH Supplementary Concept]
- nicainoprol [MeSH Supplementary Concept]
- nipradilol [MeSH Supplementary Concept]
- nofedone [MeSH Supplementary Concept]
- oxycardin [MeSH Supplementary Concept]
- oxypropanolamine [MeSH Supplementary Concept]
- pacrinolol [MeSH Supplementary Concept]
- pafenolol [MeSH Supplementary Concept]
- pamabrom [MeSH Supplementary Concept]
- pamatolol [MeSH Supplementary Concept]
- phosphatidyl-1-aminopropan-2-ol [MeSH Supplementary Concept]
- primidolol [MeSH Supplementary Concept]
- rhizobitoxine [MeSH Supplementary Concept]
- ro 363 [MeSH Supplementary Concept]
- ronactolol [MeSH Supplementary Concept]
- salcardolo [MeSH Supplementary Concept]
- serinol [MeSH Supplementary Concept]
- siladenoserinol A [MeSH Supplementary Concept]
- talinolol [MeSH Supplementary Concept]
- tazolol [MeSH Supplementary Concept]
- tert-butylbetaxolol [MeSH Supplementary Concept]
- tertatolol [MeSH Supplementary Concept]
- tibalosin [MeSH Supplementary Concept]
- tienoxolol [MeSH Supplementary Concept]
- tiprenolol [MeSH Supplementary Concept]
- tobanum [MeSH Supplementary Concept]
- tolamolol [MeSH Supplementary Concept]
- toliprolol [MeSH Supplementary Concept]
- triisopropanolamine [MeSH Supplementary Concept]
- vanilol [MeSH Supplementary Concept]
- vaninolol [MeSH Supplementary Concept]
- wiskostatin [MeSH Supplementary Concept]
- xibenolol [MeSH Supplementary Concept]
- xipranolol [MeSH Supplementary Concept]
- zami 1327 [MeSH Supplementary Concept]
Semantic type(s)
- Organic Chemical [UMLS semantic type]
- Pharmacologic Substance [UMLS semantic type]
UMLS correspondences (same concept)
- Propanolamine (substance) [SNOMED CT concept]

Keyword's position in hierarchy(ies) :

Main resources

You can consult :

recommendations
documents concerning education
documents for patients